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Dynamic interactions between RhoA and Rac1,
members of the Rho small GTPase family, play a vital
role in the control of cell migration. Using predictive
mathematical modeling, mass spectrometry-based
quantitation of network components, and experi-
mental validation in MDA-MB-231 mesenchymal
breast cancer cells, we show that a network contain-
ing Rac1, RhoA, and PAK family kinases can produce
bistable, switch-like responses to a graded PAK inhi-
bition. Using a small chemical inhibitor of PAK, we
demonstrate that cellular RhoA and Rac1 activation
levels respond in a history-dependent, bistable
manner to PAK inhibition. Consequently, we show
that downstream signaling, actin dynamics, and cell
migration also behave in a bistable fashion, display-
ing switches and hysteresis in response to PAK inhi-
bition. Our results demonstrate that PAK is a critical
component in the Rac1-RhoA inhibitory cross-
talk that governs bistable GTPase activity, cell
morphology, and cell migration switches.
INTRODUCTION
The members of the Rho family of small guanosine triphospha-
tase (GTPases), RhoA and Rac1, play crucial roles in a range
of cellular functions, including the regulation of the actin cyto-
skeleton, cell polarity and migration, gene expression, and cell
proliferation (Jaffe and Hall, 2005; Takai et al., 2001). Rho
GTPases function as molecular switches, cycling between inac-
tive guanosine diphosphate (GDP)-bound (‘‘off’’) and active38 Cell Systems 2, 38–48, January 27, 2016 ª2016 The AuthorsGTP-bound (‘‘on’’) states. In their ‘‘on’’ state, Rho GTPases
can bind downstream effector proteins, initiating signaling
through multiple pathways. The GTPase activation-deactivation
cycle is tightly controlled by two opposing enzyme groups,
(1) guanine exchange factors (GEFs), which facilitate switching
fromGDP to guanosine triphosphate (GTP), and (2) GTPase-acti-
vating proteins (GAPs), which stimulate GTP to GDP hydrolysis.
Active Rho family GTPases, Rac1 and RhoA, induce the mem-
brane translocation of downstream effectors and trigger their
activation, which commonly involves post-translational modifi-
cations and conformational changes of bound proteins (Bos
et al., 2007; Bustelo et al., 2007). Membrane-bound Rac1-GTP
recruits p21-activated kinases (PAKs) by binding to their
Cdc42-Rac interactive binding (CRIB) domain. In resting cells,
type I PAKs are localized in the cytoplasm as inactive dimers,
with the regulatory domain shielding the kinase domain. Rac1
binding induces a conformational change and subsequent
activation of PAKs, which then can phosphorylate downstream
substrates. The PAKs’ activity converts the local activation of
Rho-type GTPases into cell-wide responses (Bokoch, 2003;
Zhao and Manser, 2012).
Rac1 and RhoA, along with their fellow Rho GTPase family
member Cdc42, work in a coordinated fashion to control cell
migration (for reviews, see Burridge andWennerberg, 2004; Parri
and Chiarugi, 2010; Ridley et al., 2003). Rac1 is responsible for
driving actin polymerization at the leading edge of a migrating
cell, resulting in the formation of lamellipodia, which pushes
the cell membrane forward (Nobes and Hall, 1995, 1999; Parri
and Chiarugi, 2010; Ridley et al., 1992). Rac1 also promotes
focal complex assembly (Nobes and Hall, 1995; Parri and Chiar-
ugi, 2010) and is essential for migration (Nobes and Hall, 1999).
RhoA is required for cell adhesion (Nobes and Hall, 1999). It stim-
ulates contractility in cells through myosin light-chain (MLC)
phosphorylation, which induces the formation of stress fibers
and focal adhesions (Chrzanowska-Wodnicka and Burridge,
Figure 1. Reaction Scheme and Schematic Interactions of the Rac1-RhoA Network Model
(A) Reaction scheme of the kinetic Rac1-RhoA model showing three layers of interconnected regulation of Rac1 and RhoA via PAK (see main text and the
Supplemental Information for more details). iPAK and pPAK indicate inactive and active PAK, respectively; we denote PAK Inh as a general but selective PAK
inhibitor; and Rac1-GTP, and RhoA-GTP indicate the GTP-bound, active forms of Rac1 and RhoA, respectively.
(B) An abstract-level, schematic diagram of the Rac1-RhoA network shows the flow of signaling and highlights the double-negative feedback regulation between
Rac1 and RhoA.1996; Ridley and Hall, 1992). From the perspective of cell
morphology, Rac1 and RhoA oppose each other. Although the
picture is likely more complicated (see Discussion), canonical
descriptions of cell migration place active Rac1 at the migrating
cell’s front and active RhoA at its back. Biochemically, Rac1 and
RhoA are generally found to interact in mutually antagonistic
ways, playing opposing roles in cell migration (Ohta et al.,
2006; Sanz-Moreno et al., 2008; reviewed in Guilluy et al., 2011).
Double-negative feedback loops resulting from mutual inhibi-
tion can lead to bistability (Kholodenko, 2006). A bistable system
can flip between two biochemically distinct steady states; in the
proper context, these steady states can promote different
cellular phenotypes. Thus, the existence of bistability enables
switch-like behaviors in which a graded, analog change in signal
inputs could cause abrupt, digital responses in signaling outputs
(Ferrell, 2002; Tyson et al., 2003). Bistability has been observed
in many biological systems, including the mitogen-activated
protein kinase (MAPK) family cascades (Bhalla et al., 2002; Mar-
kevich et al., 2004, 2006; Xiong and Ferrell, 2003) and Cdc2 acti-
vation circuit (Pomerening et al., 2003; Sha et al., 2003), which
play important roles in diverse cellular functions such as devel-
opment and memory (Ogasawara and Kawato, 2010). Although
it was suggested that mutual inhibition between Rac1 and
RhoA may result in bistable activity responses (Jilkine et al.,
2007; Symons and Segall, 2009; Tsyganov et al., 2012), this
behavior and the consequences for cell migration have not yet
been experimentally observed. Here, we combine kinetic
modeling and experimentation to demonstrate the existence of
bistability in the Rac1-RhoA signaling system of highly motile
MDA-MB-231 cells. Model analysis and simulations predict
that graded changes in PAK activity induce bistable responses
of Rac1 and RhoA activities, which are experimentally validated.Furthermore, the bistable properties of the Rac1-RhoA biochem-
ical circuitry are translated into bistability of the actin dynamics
and cell migration.
RESULTS
Mathematical Modeling of the Rac1-RhoA Interaction
Network
To explore the signaling properties of the Rac1-RhoA network,
we developed a kinetic model of the network circuitry that cap-
tures main molecular events including protein-protein interac-
tions, GTPase activation and deactivation, phosphorylation
and dephosphorylation, and feedback regulations. A detailed re-
action scheme of the Rac1-RhoA network is given in Figure 1A,
while Figure 1B presents a schematic diagram showing the
signal flow in the network among Rac1, RhoA, and PAK. The
model is formulated as a system of ordinary differential equa-
tions using a combination of mass-action and enzyme kinetics
laws and is fully described in the Supplemental Information.
Our kinetic model is tailored to MDA-MB-231 cells, where
GEF-H1 is one of the dominant RhoA GEFs (Heck et al., 2012;
von Thun et al., 2013). The model assumes that Rac1 activates
PAK by binding to the PAK CRIB domain, causing a conforma-
tional transition of PAK. This exposes PAK’s activation loop,
which is subsequently auto-phosphorylated through an intra-
molecular mechanism, resulting in full activation of the kinase
(Bokoch, 2003; Zhao and Manser, 2012). Activated PAK phos-
phorylates GEF-H1, a GEF for RhoA, on inactivating inhibitory
sites (Zenke et al., 2004). Following phosphorylation, GEF-H1
binds to 14-3-3 protein, a small, phospho-motif binding, dimeric
adaptor protein, which causes the GEF-H1 relocation to micro-
tubules (Zenke et al., 2004), where its activity substantiallyCell Systems 2, 38–48, January 27, 2016 ª2016 The Authors 39
Figure 2. The Rac1-RhoA Double-Negative
Feedback Loop Can Result in Bistable
Behavior
(A) Active RhoA-GTP responses to increasing
Rac1 abundance in a bistable manner, resulting in
abrupt switches of activity level. SS, Steady State.
(B) Two-parameter (2D) bifurcation diagrams
showing dependence of bistability on the abun-
dance of Rac1 and RhoA.
(C) A parallel coordinate plot showing the bistable
parameter sets (purple) obtained by assessing the
dynamics of 100,000 sets with randomly sampled
Rac1, RhoA, PAK, GEF-H1, and 14-3-3 totals
within the indicated ranges (in nanomolars). The
values are normalized between 0 and 1. A detailed
description of the multi-dimensional dynamic
analysis and parallel coordinate representation is
given in Nguyen et al. (2015) and Supplemental
Experimental Procedures.
(D) An intuitive simplified illustration of the
bistable region in the corresponding 5D parameter
space.
(E and F) Simulated bistability and hysteresis for
active Rac1 and RhoA in response to increasing
the PAK inhibitor level. All simulations were carried
out with parameter values given in Table S4.decreases (Krendel et al., 2002). In this way, Rac1 inhibits RhoA
activity through PAK, seen as the downward negative regulation
from Rac1 to RhoA in Figure 1B.
We have experimentally shown that expression of constitu-
tively active RhoA (RhoAV14) in MDA-MB-231 cells decreases
the level of active Rac1 (Figure S1). There are several potential
routes for the inhibition of Rac1 by RhoA, including through the
regulation of RacGAPs, e.g., ARHGAP22 (Sanz-Moreno et al.,
2008) and FilGAP (Saito et al., 2012), which are phosphorylated
and activated by the Rho effector kinase ROCK. In ourmodel, we
assume that active RhoA deactivates Rac1 via activation of Rac1
GAPs (Figure 1A). This constitutes a negative regulation from
RhoA to Rac1, as depicted in Figure 1B, closing a double-nega-
tive feedback loop between Rac1 and RhoA.
To determine the abundance of the proteins in the network, we
quantified the concentration of the proteins by quantitative mass
spectrometry. Several mass spectrometry methods have been
developed that use the sumof peptide ion current integrals to es-
timate absolute protein concentrations. Overall, the error of
these methods will be below one order of magnitude and will
mostly be within a 2-fold window for abundant proteins (Li
et al., 2014; Schwanha¨usser et al., 2011). Using a combination
of filter-aided sample preparation (Wisniewski et al., 2009) and
the proteome ruler approach (Wisniewski et al., 2014), we quan-
tified the 5,000 most abundant proteins in MDA-MB-231 cells.
PAK2 is the only PAK isoform we identified in this dataset.
GEF-H1 and p115-RhoGEF are the most highly expressed
RhoA GEFs, and Rac1 and RhoA are the most abundant iso-
forms among the Rac and Rho family in these cells (Tables S540 Cell Systems 2, 38–48, January 27, 2016 ª2016 The Authorsand S6). p115-RhoGEF is mostly active
downstream of G protein-coupled recep-
tors and was consequently omitted from
the model. However, GEF-H1 has beenshown to be a major contributor toward RhoA activity in this
cell line (von Thun et al., 2013). Our model therefore considers
only these Rac, Rho, and PAK isoforms andGEF-H1. Thismakes
themodel simple enough for efficient analysis, yet it captures the
most essential biological interactions.
Bistable Switch-like Responses in the Modeled
Rac1-RhoA System
To determine MDA-MB-231 cell-specific parameters, we
measured the expression levels of key proteins incorporated in
the model, including Rac1, RhoA, PAK, GEF-H1, and 14-3-3,
by quantitative mass spectrometry (Table S5). After populating
the model with these values (see Supplemental Information)
and carrying out extensive simulations of steady-state dose re-
sponses, bistability of the Rac1-RhoA system was observed in
a wide parameter range. In the bistable parameter region,
Rac1 and RhoA activity levels responded in a switch-like manner
to graded changes in levels of various species. For example, Fig-
ure 2A shows a model simulation in which the active RhoA-GTP
displays a bistable response to the graded increase in the total
Rac1 abundance. We can see that active RhoA levels suddenly
jump from a high to a low state when Rac1 gradually increases
from an initial low abundance (dashed, green line, Figure 2A),
while the backward traverse of Rac1, that is, starting at a high
abundance and gradually reducing the total amount of Rac1,
abruptly pushes active RhoA from a low to a high state at a
different, lower Rac1 threshold (dashed, purple line, Figure 2A).
A system’s ability to have two quantitatively different thresholds,
associated with each of two quantitatively different starting
states, defines the so-called hysteresis phenomenon. Hysteresis
is a hallmark of bistable dynamics (Kholodenko, 2006).
Although the ability to support bistable dynamics is a feature of
this network’s structure, bistable behavior only occurs at certain
parameter values. When parameters are changed, bistability can
occur or disappear. Such dramatic changes in the system dy-
namic behavior are called bifurcations. If two parameters are
selected, a two-dimensional (2D) plane of these parameters
can be conveniently divided into areas where bistability is pre-
sent or the GTPase network has a single steady state (called
monostability). This partitioning of the parameter space, often
referred to as 2D bifurcation diagrams, enables one to discern
how changes in the abundances of different model species
affect the occurrence and existence of bistability, that is, its
robustness. Figure 2B displays a 2D bifurcation plot showing
the system is bistable over a large region (in purple) of the
Rac1 and RhoA abundances at the assumed physiological ki-
netic parameter values, while the remaining region exhibits
monostability (in light green). Next, we investigated the depen-
dence of bistability in more than two dimensions when multiple
model parameters are allowed to simultaneously change. This
analysis helped us understand the system dynamics in the
multi-dimensional parameter space.
To visualize multi-dimensional parameter settings in which
bistability is present or absent, we use a software program
DYVIPAC (see Supplemental Experimental Procedures and Fig-
ure S2, which illustrates the DYVIPAC methodology) (Nguyen
et al., 2015). Figure 2C displays the results of multi-dimensional
parameter analysis in the form of parallel coordinate plots where
the abundances of five model species, Rac1, RhoA, PAK, GEF-
H1, and 14-3-3, are allowed to change within physiologically
sensible ranges (here, from 0 to 1,000 nM). Systematic sampling
of 100,000 sets in this five-dimensional (5D) parameter space for
DYVIPAC analysis shows that the system can display either bi-
stable or monostable behavior. For ease of visualization, Fig-
ure 2C displays only the bistable sets using the same color, while
individually color-coded bistable sets could be seen in Fig-
ure S3B alone or with the monostable sets in Figure S3A. Fig-
ure 2C indicates that bistability occurs for a large number of
parameter sets.
Bistability is found to strongly associate with high RhoA, PAK,
and 14-3-3 abundances but low GEF-H1 abundance, while bist-
ability may occur at both high and low Rac1 levels. When we
overlay the measured protein levels for MDA-MB-231 cells, we
observe that the MDA-MB-231-specific values appear to be
within the bistable region (Figure 2C) for the assumed values of
kinetic constants. A more intuitive visualization of bistable region
in the 5D parameter space is given in Figure 2D. For larger sam-
pling ranges (0 to 5,000 nM) our analysis reveals similar patterns
of the bistable region, suggesting that relative rather than abso-
lute values of these species determine the occurrence of bist-
ability (Figure S4). Similar analysis describing the effect of the
kinetic parameters on the bistable region (Figures S5 and S6)
and the behavior of a comparable dimensionlessmodel (Supple-
mental Experimental Procedures and Figure S7) demonstrates
that this system’s bistable region is wide.
Rac1 and RhoA do not act in isolation inside the cell, but
through their immediate effectors, PAK and ROCK, these
GTPases regulate cytoskeleton dynamics and cell migration.Because PAK activity can be perturbed experimentally, we
next asked how Rac1 and RhoA activity would behave in
response to PAK inhibition. To this end, we extended our model
to include PAK inhibition, which is described as a reaction in
which a PAK inhibitor binds to inactive, unphosphorylated
PAK, competing with PAK binding to Rac1-GTP (reactions 14
and 15, Figure 1A) (Deacon et al., 2008; Viaud and Peterson,
2009). Model simulations suggest that active RhoA and Rac1
display bistable, switch-on and switch-off responses, respec-
tively, to increasing PAK inhibitor levels (Figures 2E and 2F).
Within a defined range of inhibitor concentration, active Rac1
and RhoA achieved one of two stable steady states (solid lines,
Figures 2E and 2F) but could not settle in the intermediate, un-
stable one (dashed lines, Figures 2E and 2F). At low inhibition
levels, RhoA-GTP could display a single low steady-state value.
As the inhibitor level increases, active RhoA rises slowly until it
reaches a threshold level (T1) at which it suddenly switches to a
high state (purple dashed lines, Figure 2E). In contrast, when
the high active RhoA state is initially induced by the high PAK
inhibitor levels and then the inhibitor level decreases, active
RhoA slowly decreases until it reaches a second, lower
threshold (T2) at which active RhoA drops precipitously and
switches to a low state (green dashed line, Figure 2E). Similarly,
active Rac1 reacts in a bistable manner to the PAK inhibitor,
although in an opposite fashion to RhoA (Figure 2F). A 2D bifur-
cation analysis further shows that bistability occurs within a
bounded range of inhibitor concentration (Figures S8A and
S8B). When we vary the levels of the key model species within
2-fold of their measured values in MDA-MB-231, RhoA-GTP
and Rac1-GTP continue to exhibit bistable responses to
graded PAK inhibition but the switching thresholds are param-
eter dependent (Figures S8C and S8D). Thus, our model anal-
ysis suggests that Rac1 and RhoA activities can display robust
bistable responses to PAK inhibition.
Experimental Validation of Bistable Switches of Rac1
and RhoA Activity Levels
Here, we test model predictions experimentally using the MDA-
MB-231 human breast cancer cell line. These experiments rely
on chemical inhibition of PAK, because small molecule inhibi-
tors, which are quickly imported and exported from cells, can
reach equilibriumwithin the time frame of the experiments before
transcriptional feedback effects take place and the system
changes in fundamental ways. We used IPA-3, a chemical inhib-
itor that specifically targets inactive group 1 PAKs (Deacon et al.,
2008; Viaud and Peterson, 2009) by preferentially binding to the
inactive conformation of the PAKs’ regulatory domain. Accord-
ingly, it has been observed to inhibit Rac1-mediated PAK activa-
tion dose dependently, whereas IPA-3 has a substantially
reduced effect on already-active PAK (Deacon et al., 2008; Viaud
and Peterson, 2009). To determine the half-life of intercellular
IPA-3, we treated the cells with IPA-3 and replaced the media af-
ter 20 min of incubation. We then washed the cells with PBS, ex-
tracted cellular IPA-3 with methanol, and quantified it by mass
spectrometry. We found that the half-life was around 2–5 min
(Figure S9). After a 10 min washout, the cellular levels had
decreased to 10%–25% of the initial concentration, and IPA-3
levels were undistinguishable from an untreated control after
20 min.Cell Systems 2, 38–48, January 27, 2016 ª2016 The Authors 41
To determine whether RhoA and Rac1 behave in a bistable
manner in MDA-MB-231 cells, we incubated cells that initially
have low RhoA-GTP and high Rac1-GTP levels with different,
incrementally increasing concentrations of IPA-3, ranging from
0 to 15 mM, for 40 min, as indicated in Figures 3A–3D. Further-
more, to change the initial RhoA and Rac1 activities, we pre-
treated cells with the highest concentration of IPA-3 (15 mM)
for 20 min, locking the system into a high RhoA (Figures 3A
and 3B) and low Rac1 (Figures 3C and 3D) activity state. At
this point, the inhibitor was washed off, and then incrementally
increasing IPA-3 concentrations from 0 to 15 mM were added
for an additional 20 min (Figures 3A–3D; see Figure S10 for a
workflow diagram of the experiment). Active, GTP-bound RhoA
and Rac1 were precipitated with GST-Rhotekin and GST-PAK-
CRIB beads, respectively; detected using western blots; and
normalized against total RhoA and Rac1 levels (Figures 3A and
3C, respectively). Densitometric analyses of three replicates
are shown in Figures 3B and 3D. The blue curves show the re-
sponses of active RhoA and Rac1 to incrementally increasing
PAK inhibition, and the red curves show their responses to incre-
mentally decreasing PAK inhibition after being initially locked in
the state produced by high PAK inhibition (as predicted by
simulations in Figures 2E and 2F). Comparing experimental
quantifications with model predictions shows that similar
switch-like and hysteretic behaviors are present. Loading con-
trols confirm that expression levels of Rac1 and RhoA remain
stable over the course of the experiment, thus excluding the pos-
sibility that the observed hysteresis is the consequence of
altered protein expression in response to PAK inhibition.
Bistability of Signaling Downstream of RhoA
Having determined that active Rac1 and RhoA behave in a bista-
ble manner in response to PAK inhibition, we wanted to see
whether molecular events downstream of the GTPases behave
similarly. RhoA-GTP can bind and activate Rho kinase (ROCK),
which in turn inhibits MLC phosphatase, as well as directly phos-
phorylatingMLC (Nobes andHall, 1999). In addition to phosphor-
ylating MLC via ROCK, active RhoA has been shown to increase
the formation of actin stress fibers by enhancing actin nucleation
and reducing actin depolymerization (Chesarone and Goode,
2009; Ridley and Hall, 1992). Thus, we decided to determine
whether IPA-3 could increase stress fiber formation and phos-
phorylated MLC (pMLC). F-actin stress fibers and pMLC can be
imaged by phalloidin staining and by immunofluorescence,
respectively. Both readouts can be quantified by high-content
microscopy. In addition to quantifying changes at the population
level, this approach would allow us to determine F-actin and
pMLC at the single-cell level. These data would reveal how the
distribution of either marker of RhoA activity was changed in
response to PAK inhibition within the cell population.
We seeded MDA-MB-231 cells in collagen-coated 96-well
plates and treated the cells with increasing concentrations of
IPA-3 for 80 min (non-pretreated). Alternatively, we pretreated
the cells with a high concentration of the inhibitor for 20 min,
followed by a washout and incubation with increasing concen-
trations of IPA-3 for an additional 60 min (see Figure S10 for
workflow). After the treatment was completed, we fixed, per-
meabilized, and stained the cell body, F-actin, nuclei, and
pMLC with a high-content screening cell mask, phalloidin,42 Cell Systems 2, 38–48, January 27, 2016 ª2016 The AuthorsHoechst, and specific primary and fluorescent secondary anti-
bodies (Figure 3E). We imaged the cells on a high-content auto-
mated microscope and processed the acquired images to
isolate individual cells and further segment the cells into nucleus,
cell body, and lamellipodium (Figure S11A). When we plotted the
median intensity of cellular lamellipodial pMLC, we observed
hysteresis (Figure S11B). In non-pretreated cells, IPA-3
increased pMLC intensity at the highest concentrations,
whereas when cells were pretreated, we observed that the
switch occurred at the lowest concentrations (Figure S11B).
We then plotted single-cell lamellipodial pMLC levels in a histo-
gram to observe whether IPA-3 levels altered the distribution of
pMLC in the cell populations. In MDA-MB-231 without any
IPA-3 treatment, pMLC was spread in a long-tailed distribution,
possibly already containing two populations with distinct popu-
lation averages (Figure 3F). This distribution was unaltered for
the low and medium concentrations of the inhibitor, but we
observed a broadening at the highest IPA-3 concentration (Fig-
ure 3F). In cells that were pretreated with IPA-3, we observed
that the broadening of the pMLC distribution already occurred
at low inhibitor concentrations (Figure 3G). The broadening of
the distributions suggests that two, possibly three, cell popula-
tions with distinct average pMLC levels can be present under
these conditions. This potentially multi-modal distribution sug-
gests that pMLC levels may be determined by more complex
signaling, which is not captured in its entirety by our model.
We then quantified cytoplasmatic F-actin in the same sample
set. Analogous towhatwe observedwith pMLC, only higher con-
centration of IPA-3 increased cellular F-actin (Figure S11C). In
contrast, pretreating the cells increased the cellular quantity of
F-actin across all IPA-3 concentrations (Figure S11C). We then
plotted the F-actin single-cell distribution and observed that
most non-pretreated MDA-MB-231 cells had no or low amounts
of stress fibers at low or medium inhibitor concentrations. Incu-
bation with 7.5 mM IPA-3 gave rise to a second population that
was positive for F-actin (Figures 3H and 3I). Pretreatment with
IPA-3 for 20 min was also sufficient to increase the presence
of this second population (Figure 3J). Washing IPA-3 completely
off reduced the levels of the stress fiber-containing cells but not
to the levels of the initial condition, suggesting that 20 min of
IPA-3 induced actin stress fibers irreversibly within the time
frame of the experiment. This is possibly due to the stability of
the stress fibers, and 1 hr may not be enough to efficiently disas-
semble them. In summary, these data showed that both pMLC
and F-actin are induced by IPA-3. Instructively, we observed
hysteresis for both markers of RhoA activity. Furthermore, our
data showed that F-actin is bimodally distributed, and there is
a likelihood that this was the case for pMLC.
Bistable Behavior of Actin Dynamics
Given the requirement of Rac1 and RhoA interactions for actin
assembly and disassembly (Burridge and Wennerberg, 2004;
Nobes and Hall, 1995; Ridley and Hall, 1992) and in initiating pro-
trusions at the leading edge (Machacek et al., 2009; Pertz et al.,
2006), we speculated that IPA-3 would also regulate actin dy-
namics in a bistable fashion, a hypothesis we tested next.
Live-cell actin polymerization dynamics can be visualized by
expressing fluorescent proteins tagged to an F-actin binding
peptide (LifeAct) (Riedl et al., 2008). Therefore, we generated
Figure 3. Experimental Validation of RhoA and Rac1 Bistable Switches in MDA-MB-231 Cells
(A–D) PAK was inhibited in MDA-MB-231 cells by adding specific inhibitor IPA-3 at the indicated concentrations for 40 min (blue) or by incubating MDA-MB-231
cells with 15 mM IPA-3 for 20 min. The inhibitor was subsequently washed out, and the cells were incubated for an additional 20 min with IPA-3 at the indicated
concentrations (red). (A) RhoA-GTP was precipitated with GST-Rhotekin beads and western blotted. (B) Densitometric analysis of three biological replicates.
Error bars represent SD. (C) Rac1-GTPwas precipitated withGST-PAK-CRIB beads andwestern blotted. (D) Densitometric analysis of three biological replicates.
Error bars represent SD.
(E)MDA-MB-231 cells seeded on collagen were treated for 80minwith the indicated concentrations of IPA-3, fixed and stainedwith an anti-pS19MLC2 antibody.
203 image.
(F)MDA-MB-231 cells seeded on collagen were treated for 80minwith the indicated concentrations of IPA-3, fixed and stainedwith an anti-pS19MLC2 antibody.
Histogram of single-cell, averaged lamellipodial intensity.
(G) MDA-MB-231 cells seeded on collagen were treated for 20 min with 7.5 mM IPA-3. The cells were subsequently washed and treated for an additional 60 min
with the indicated concentrations of IPA-3, fixed and stained with an anti-pS19 MLC2 antibody. Histogram of single-cell, averaged lamellipodial intensity.
(H) MDA-MB-231 cells seeded on collagen were treated for 80 min with the indicated concentrations of IPA-3, fixed and stained with fluorescent phalloidin.
203 image.
(I) MDA-MB-231 cells seeded on collagen were treated for 80 min with the indicated concentrations of IPA-3, fixed and stained with fluorescent phalloidin.
Histogram of single-cell, averaged cytoplasmatic intensity.
(J) MDA-MB-231 cells seeded on collagen were treated for 20 min with 7.5 mM IPA-2. The cells were subsequently washed and treated for an additional 60 min
with the indicated concentrations of IPA-3, fixed and stained with fluorescent phalloidin. Histogram of single-cell, averaged cytoplasmatic intensity.
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Figure 4. Actin Dynamics Behave in a Bista-
ble Manner in Response to PAK Inhibition
Sparsely seeded MDA-MB-231 cells expressing a
LifeAct-mCherry probe were treated with the PAK
inhibitor IPA-3 (A) at the indicated concentrations
for 60 min (blue) or (B) by incubating cells with
7.5 mM IPA-3 for 20 min. The inhibitor was sub-
sequently washed out, and the cells were incu-
bated for an additional 60 min with IPA-3 at the
indicated concentrations (red). Images were taken
every 15 s. Montage images represent changes in
actin dynamics during the cells’ migration,
showing three images (0, 30, and 60 min) over the
1 hr period. Scale bar, 20 mM.MDA-MB-231 cells that stably express mCherry-tagged LifeAct.
Similar to earlier, we exposed cells in their normal state to incre-
mentally increasing concentrations of IPA-3. Alternatively, we
first pretreated cells with high IPA-3 doses for 20min, thereby in-
hibiting PAKs, and then washed out the inhibitor and again incu-
bated cells with different IPA-3 concentrations. In both cases, we
imaged the actin dynamics over 60min (see Figure S10 for work-
flow). Untreated control cells exhibited a highly dynamic F-actin
cytoskeleton, which rapidly pushed and retracted cellular protru-
sions and lamellipodia (Figure 4A; Movie S1). Low concentra-
tions of IPA-3 (1.875 and 3.75 mM) did not affect the dynamic
behavior, whereas high concentrations (7.5 mM) initially froze
the actin polymerization (Figure 4A;Movies S2, S3, and S4). Sub-
sequently, some cells contracted and membrane blebs ap-
peared (Movie S4), which is indicative of high RhoA activity. In
isolated cases, the cells even detached from the glass surface.
Equally, pretreatment of the cells with high concentrations of
IPA-3 resulted in stalling actin dynamics, blebbing, and a con-
tracted phenotype (Figure 4B; Movies S5, S6, S7, and S8).
When the IPA-3 concentration was dropped below 3.75 mM,
actin dynamics recovered, blebbing was reduced, and the cells
started spreading and initiating lamellipodia (Figure 4B; Movies44 Cell Systems 2, 38–48, January 27, 2016 ª2016 The AuthorsS5 and S6). In contrast, cells in which
the IPA-3 concentration was not altered
or reduced to 3.75 mM did not recover
and remained in a frozen state (Figure 4B;
Movie S7). Taken together, these data
show that analogous to RhoA- and
Rac1-GTP, actin dynamics respond in a
bistable manner when perturbed by PAK
inhibition.
Bistable Behavior of Cell Migration
Actin-driven cellular protrusions and
retrograde flow are essential for efficient
cell migration. It has been previously
demonstrated that Rac activity is required
for cell migration and that global inhibition
of Rac arrests cell migration (Nobes and
Hall, 1999). Therefore, based on our
observation that IPA-3 affects actin dy-
namics and Rac1 activity levels in a bista-
ble manner, we hypothesized that cell
migration should behave analogously.To test this hypothesis, we next measured how migration of
MDA-MB-231 cells was affected by PAK inhibition, performing
random and directed migration assays. Random migration is
the expression of the intrinsic cell directionality in the absence
of any external guiding factor, whereas directed migration re-
quires steering by an external guidance cue (Petrie et al.,
2009). In both cases, the interplay and localization of Rac1 and
RhoA activity determine migration speed and directionality.
To determine random migration speed, cells were seeded at
low confluency and treated with incrementally increasing con-
centrations of IPA-3 ranging from 0 to 7.5 mM. An additional
set of cells was treated with the highest concentration of
IPA-3, 7.5 mM for 20 min. IPA-3 was then washed off and re-
placed with incrementally increasing inhibitor concentrations
from 0 to 7.5 mM IPA-3, as indicated in Figure 5A. The IPA-3
concentrations are slightly different from those used in Figures
3A–3D due to batch-to-batch variability. Preliminary migration
experiments done using IPA-3 from the first batch showed that
full migration inhibition required 15 mM IPA-3 (Figure S12A). We
took transmission-light images every 20 min for 12 hr, and the
path of migration of individual cells was manually tracked (see
Figure S10 for workflow). The migration paths of individual cells
Figure 5. Migration of MDA-MB-231 Cells Is Regulated in a Bistable Manner by PAK
(A) Undirected cell migration. Sparsely seededMDA-MB-231 cells were treated with the PAK inhibitor IPA-3 at the indicated concentrations for 40min (blue) or by
incubatingMDA-MB-231 cells with 7.5 mM IPA-3 for 20min. The inhibitor was subsequently washed out, and the cells were incubated for an additional 20minwith
IPA-3 at the indicated concentrations (red). Images were taken every 20 min, and random cell migration of 25 cells was subsequently manually tracked using
ImageJ. Each line represents a single cell’s migration in one field of view over 12 hr. The line color shows the distance migrated from 0–3 hr (red), 3–6 hr (orange),
6–9 hr (green), and 9–12 hr (blue). Line origins have been artificially placed at (0,0) for display purposes, but lengths remain unchanged. The width and height of
each plot is 200 mm.
(B) The mean speed ± SD of three single-cell tracking biological replicates over 12 hr, a representative example of which is found in Figure 5A. The differences
between pretreated and non-pretreated 1.185, 2.5, and 3.75 mM IPA-3 were all statistically significant, with p = 0.017, 0.015, and 0.0001, respectively, measured
using a two-tailed, non-paired t test. Error bars represent SEM.
(C) Directed cell migration. Confluent MDA-MB-231 cells were scratchedwith a plastic tip. IPA-3 was added at the indicated concentrations for the duration of the
experiment (blue) or by incubating MDA-MB-231 cells with 15 mM IPA-3 for 20 min. The inhibitor was subsequently washed out, and the cells were incubated for
the remainder of the experiment with IPA-3 at the indicated concentrations (red). Images of the wound were taken at 0 and 18 hr.
(D) Graph representing the percentage of wound closure of three biological replicates. Error bars represent SD.
(E) MDA-MB-231 cells were sparsely seeded on a thick collagen layer. After 24 hr, they were treated with the PAK inhibitor IPA-3 at the indicated concentrations
(non-treated) or by incubating MDA-MB-231 cells with 7.5 mM IPA-3 for 20 min. The inhibitor was subsequently washed out, and the cells were incubated with
IPA-3 at the indicated concentrations (pretreated). Images were taken 24 hr later. Histogram represents cell number over cell roundness, with 0 as an infinite line
and 1 as a perfect circle.in a representative replicate are plotted in Figure 5A to give a
visual representation of migration. The average speed of each
cell was calculated and plotted against PAK inhibition (Fig-
ure S12). The quantification in Figure 5B shows that the motility
of non-pretreated cells was unaffected at 2.5 mM IPA-3 but sub-
sequently decreased in response to linearly increasing IPA-3
concentrations. Furthermore, the transition from high to low
and then low to high migration speeds occurs at different
threshold levels of IPA-3, indicating hysteresis. Together, these
data suggest that migration of the cells is affected by PAK inhi-
bition in a bistable manner.Examining instantaneous cell velocities, we found that bist-
ability persists for the duration of the experiment (Figures S12A
and S12B). Bistable switches in migration velocity occur in indi-
vidual cells. Consequently, the change in the population cell ve-
locity average is caused by switch-like velocity changes in
different cells rather than by gradual changes in the whole pop-
ulation. Therefore, we hypothesized that under conditions in
which the system is bistable (1.865, 2.5, and 3.75 mM IPA-3),
the velocities of cells at a given time step (instantaneous veloc-
ities) would follow a bimodal distribution, which is a hallmark of
a bistable system (Birtwistle et al., 2012; Dobrzynski et al.,Cell Systems 2, 38–48, January 27, 2016 ª2016 The Authors 45
2014). Analysis of individual cell tracks from Figure 5A showed
that this was the case (Figure S12C).
We also tested the effect of PAK inhibition on directed cell
migration using a wound-healing assay. The cells were treated
as before and were photographed immediately after treatment
and again after 18 hr (see Figure S10 for workflow). A represen-
tative experiment is shown in Figure 5C. A quantification of three
replicates is shown in Figure 5D. The results show switch-like in-
hibition of cell motility in response to graded PAK inhibition. In
addition, the switch occurs at different thresholds depending
on the initial condition of the systems, indicating the presence
of hysteresis (Figures 5C and 5D). These results suggest that
directed migration features a bistable response to PAK
inhibition.
Finally, to show that the results produced by inhibition of PAK
by IPA-3 were not due to an unspecific off-target inhibitor effect,
we reproduced some of these results using an unrelated PAK
inhibitor (PAKi). PAKi, a genetically encoded PAK1-3 specific in-
hibitor consisting of a truncated PAK1 regulatory domain, in-
cludes the kinase-binding segment that can bind to and inhibit
the catalytic domain of PAK1-3 but does not have an intact
CRIB domain and therefore cannot bind Rac1 directly (Volinsky
et al., 2006). Expression of GFP-coupled PAK (PAKi) or an inac-
tive mutant (PAKi-2 m) was induced by transient transfection in
MDA-MB-231 cells. This alternative PAK inhibitor also inhibited
Rac1 activity and migration (Figure S13), whereas the inactive
mutant had no effect on either. These results confirm that these
observed effects are specific to PAK inhibition.
Bistability and Bimodality of Cell Morphology in 3D
Matrices
Cells embedded in three-dimensional (3D) matrices have been
shown to invade into the surrounding area by two fundamentally
disparate modes of migration (Friedl and Alexander, 2011):
mesenchymal and amoeboid. Mesenchymal migration requires
cells to proteolytically degrade the matrix through the secretion
of matrix metalloproteases (MMPs). This migration mode re-
quires high Rac1-GTP, and it is independent of RhoA activity.
Amoeboid migration, however, is independent of MMPs but re-
quires RhoA activity. This migration type is driven by actinomyo-
sin contractility and characterized by a roundedmorphologywith
high RhoA activity.
MDA-MB-231 cells have predominantly elongated mor-
phology in 3D matrices but switch to a rounded cell shape
upon RhoA activation or MMP inhibition (von Thun et al., 2013).
Thus, we hypothesized that RhoA-GTP elevated by IPA-3 treat-
ment may also alter the morphology of MDA-MB-231 cells. This
transition between two morphologies is driven by the RhoA ac-
tivity changes. Thus, we would expect that, analogous to what
we have seen at the molecular level, this switch would be
bistable.
To test whether this was the case, we seeded MDA-MB-231
cells on a thick layer of collagen and allowed them to invade
the collagen gel over 24 hr. We then incubated the cells either
with a range of IPA-3 concentrations or with a 20 min burst of
7.5 mM IPA-3, which was replaced by a set of IPA-3 dilutions.
We then imaged the cells embedded in the collagen matrix
and determined their shape by automated image analysis (see
Figure S10 for workflow). As expected, MDA-MB-231 cells46 Cell Systems 2, 38–48, January 27, 2016 ª2016 The Authorsadopted an elongated phenotype in a collagenmatrix (quantified
in Figure 5E). The 7.5 mM IPA-3 shifted most of the population to-
ward a rounded phenotype. At the intermediate concentration of
3.75 mM IPA-3, we could observe that the distribution of the
roundness within the cell population was bimodal. Pretreatment
with IPA-3 followed by a washout shifted the switch concentra-
tion. In this case, we observed bimodality at the lower concentra-
tion of 1.875 mM IPA-3, whereas the cells were predominantly
rounded at 3.75 and 7.5 mM IPA-3 (Figure 5E). Taken together,
these data showed that the change in morphology is likely to
be bistable, because we observed that the IPA-3 concentration
needed to induce the switch depends on the initial condition.
In addition, we observed bimodality, a general feature of bistable
systems.
DISCUSSION
Rac1 and RhoA are embedded in a wider network of interactions
containing extra positive feedback regulations, which were not
included in our models. For example, a positive feedback be-
tween Rac1 and PAK is formed via the protein Cool-2 (cloned
out of library-2) (Baird et al., 2005; Feng et al., 2002), and Rac1
can positively regulate itself in a PAK-independent manner (Tsy-
ganov et al., 2012). However, adding these feedbacks to the sys-
tem with existing double-negative feedback, or incorporating
GDP dissociation inhibitors in the model, only enlarges the bist-
ability range; it did not significantly affect the network behavior
(Figure S14) (Nikonova et al., 2013).
For cells to migrate effectively, there must be a highly coordi-
nated interplay between protrusion extension and both adhesion
formation and rear end retraction driven by high Rac1 and high
RhoA activities, respectively. The high activity of one GTPase re-
quires the low activity of the other to ensure that there is no con-
flict in the organization of the actin cytoskeleton. The traditional
view of Rac1 and RhoA activity in migrating cells was of high
Rac1 activity only at the leading edge and high RhoA activity
only at the trailing edge. This hypothesis of wide spatial segrega-
tion of Rac1 and RhoA activities has since been challenged by
localization experiments that describe RhoA activity at the lead-
ing edge of migrating cells (Machacek et al., 2009; Pertz et al.,
2006) and Rac1 activity at the tail (Gardiner et al., 2002). Though
there seems to be a lack of consensus over the exact localiza-
tions of active RhoA and Rac1 during the cell movement, and
we are likely only seeing a small part of a larger, more complex
picture (Wang et al., 2013), a unifying motif is that the activation
zones of Rac1 and RhoA are mutually exclusive, either spatially
or temporally (Guilluy et al., 2011; Pertz, 2010). This exclusivity
found in the spatial and temporal localization of Rac1 and
RhoA has been proposed to arise from the bistability of the sys-
tem (Jilkine et al., 2007; Semplice et al., 2012). Bistability allows
the cell (or area of a cell) to make a discrete digital decision in the
face of a range of conflicting external signal gradients and en-
sures that the decision made by the cell is fairly robust. In that
way, the cell is responsive to its surroundings but not so sensitive
that it is unable to make efficient progress.
Due to the hysteresis present in the system, once PAK is
inhibited, it remains locked in that state even at lower inhibitor
concentrations. Such circuitries with bistable and hysteretic
response characteristics could make attractive targets for
therapy approaches using dose variation, because an initial high
dose would switch the system to the inhibited state, which can
be maintained using lower drug concentrations. This behavior
is desirable for minimizing drug toxicity and in terms of pharma-
cokinetics ensuring a long-lasting inhibition even when the drug
concentrations decline. Our cell motility experiments show that
undirected and directed migration are arrested in two dimen-
sions by strong inhibition of PAK (e.g., Figure 4A). This indicates
that PAK could be an attractive drug target for blocking the
migration of cancer cells. Although IPA-3 is not suitable for clin-
ical use (Zhao andManser, 2010), our results are valid for various
mechanisms of PAK inhibition, and this may stimulate the de-
velopment of therapeutically appropriate PAK inhibitors in the
future.
EXPERIMENTAL PROCEDURES
For a detailed description of the models and model analyses, see Supple-
mental Information.
Cell Culture and Reagents
MDA-MB-231 cells were cultured using standard techniques. The plasmids,
reagents, and antibodies used in this study are listed in Supplemental
Information.
Liquid Chromatography-Tandem Mass Spectrometry, Protein
Identification and Quantitation, and IPA-3 Quantitation
Samples were analyzed on a Q Exactive mass spectrometer (Thermo
Scientific) coupled to ultra-high-performance liquid chromatography as
described (Farrell et al., 2014). Identification and quantitation was per-
formed using the MaxQuant/Perseus software suite for proteins or Xcalibur
for IPA-3.
Immunofluorescence
Standard protocols were followed. Images were acquired in an unsupervised
manner on an ImageXpress Micro wide-field microscope and were analyzed
using the MetaXpress Custom Module Editor (Molecular Devices).
Live-Cell Imaging
Standardmethodswere employed.MDA-MB-231 or a clone stably expressing
LifeAct-mCherry was seeded in an optical-bottomed plate. Images were ac-
quired on a spinning-disc laser confocal Nikon microscope, an Incucyte
ZOOM system, or a Zeiss Axiovert 200M.
Mathematical Modeling
Mathematical modeling was implemented in Mathematica v.8.0.1.0 (Wolfram
Research, 2010). Stability analysis was carried out using XPPaut and Mathe-
matica. Multi-dimensional dynamic analysis and visualization were conducted
using DYVIPAC (Nguyen et al., 2015). Bimodal data analysis and plotting was
conducted using the R package ggplot2 (Wickham, 2009).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
14 figures, 6 tables, and 8 movies and can be found with this article online
at http://dx.doi.org/10.1016/j.cels.2016.01.003.
AUTHOR CONTRIBUTIONS
Design of Project, A.v.K., L.K.N., M.R.B., and B.N.K.; Biochemical and Cell
Biological Assays, A.v.K., K.M.B., N.V., K.K., N.M., J.C.D., J.-C.B.-W.,
A.J.F., and N.O.C.; Model Development and Analysis, K.M.B., L.K.N.,
B.N.K., M.A.T., M.D., A.K., and A.D.; Manuscript Writing, W.K., K.M.B.,
A.v.K., L.K.N., and B.N.K. A.v.K., L.K.N., and B.N.K. contributed equally to
this work.ACKNOWLEDGMENTS
This work was supported by the EU Seventh Framework under projects
PRIMES (Grant No. FP7-278568), SynSignal (Grant No. 613879), and Breast
Cancer NOW (2013NovPR183). We would like to thank Olivier Pertz (Basel)
for the LifeAct, Mike Olson (Beatson) for the GST-Rhotekin, and Piero Crespo
(Santander) for GST-PAK-CRIB constructs.
Received: July 6, 2015
Revised: November 30, 2015
Accepted: January 5, 2016
Published: January 27, 2016
REFERENCES
Baird, D., Feng, Q., and Cerione, R.A. (2005). The Cool-2/alpha-Pix protein
mediates a Cdc42-Rac signaling cascade. Curr. Biol. 15, 1–10.
Bhalla, U.S., Ram, P.T., and Iyengar, R. (2002). MAP kinase phosphatase as a
locus of flexibility in a mitogen-activated protein kinase signaling network.
Science 297, 1018–1023.
Birtwistle, M.R., Rauch, J., Kiyatkin, A., Aksamitiene, E., Dobrzynski, M., Hoek,
J.B., Kolch, W., Ogunnaike, B.A., and Kholodenko, B.N. (2012). Emergence of
bimodal cell population responses from the interplay between analog single-
cell signaling and protein expression noise. BMC Syst. Biol. 6, 109.
Bokoch, G.M. (2003). Biology of the p21-activated kinases. Annu. Rev.
Biochem. 72, 743–781.
Bos, J.L., Rehmann, H., and Wittinghofer, A. (2007). GEFs and GAPs: critical
elements in the control of small G proteins. Cell 129, 865–877.
Burridge, K., and Wennerberg, K. (2004). Rho and Rac take center stage. Cell
116, 167–179.
Bustelo, X.R., Sauzeau, V., and Berenjeno, I.M. (2007). GTP-binding proteins
of the Rho/Rac family: regulation, effectors and functions in vivo. BioEssays
29, 356–370.
Chesarone, M.A., andGoode, B.L. (2009). Actin nucleation and elongation fac-
tors: mechanisms and interplay. Curr. Opin. Cell Biol. 21, 28–37.
Chrzanowska-Wodnicka, M., and Burridge, K. (1996). Rho-stimulated
contractility drives the formation of stress fibers and focal adhesions. J. Cell
Biol. 133, 1403–1415.
Deacon, S.W., Beeser, A., Fukui, J.A., Rennefahrt, U.E., Myers, C., Chernoff,
J., and Peterson, J.R. (2008). An isoform-selective, small-molecule inhibitor
targets the autoregulatory mechanism of p21-activated kinase. Chem. Biol.
15, 322–331.
Dobrzynski, M., Nguyen, L.K., Birtwistle, M.R., von Kriegsheim, A., Blanco
Ferna´ndez, A., Cheong, A., Kolch, W., and Kholodenko, B.N. (2014).
Nonlinear signalling networks and cell-to-cell variability transform external sig-
nals into broadly distributed or bimodal responses. J. R. Soc. Interface 11,
20140383.
Farrell, J., Kelly, C., Rauch, J., Kida, K., Garcı´a-Mun˜oz, A., Monsefi, N.,
Turriziani, B., Doherty, C., Mehta, J.P., Matallanas, D., et al. (2014). HGF in-
duces epithelial-to-mesenchymal transition by modulating the mammalian
hippo/MST2 and ISG15 pathways. J. Proteome Res. 13, 2874–2886.
Feng, Q., Albeck, J.G., Cerione, R.A., and Yang, W. (2002). Regulation of the
Cool/Pix proteins: key binding partners of the Cdc42/Rac targets, the p21-
activated kinases. J. Biol. Chem. 277, 5644–5650.
Ferrell, J.E., Jr. (2002). Self-perpetuating states in signal transduction: positive
feedback, double-negative feedback and bistability. Curr. Opin. Cell Biol. 14,
140–148.
Friedl, P., and Alexander, S. (2011). Cancer invasion and the microenviron-
ment: plasticity and reciprocity. Cell 147, 992–1009.
Gardiner, E.M., Pestonjamasp, K.N., Bohl, B.P., Chamberlain, C., Hahn, K.M.,
and Bokoch, G.M. (2002). Spatial and temporal analysis of Rac activation dur-
ing live neutrophil chemotaxis. Curr. Biol. 12, 2029–2034.
Guilluy, C., Garcia-Mata, R., and Burridge, K. (2011). Rho protein crosstalk:
another social network? Trends Cell Biol. 21, 718–726.Cell Systems 2, 38–48, January 27, 2016 ª2016 The Authors 47
Heck, J.N., Ponik, S.M., Garcia-Mendoza, M.G., Pehlke, C.A., Inman, D.R.,
Eliceiri, K.W., and Keely, P.J. (2012). Microtubules regulate GEF-H1 in
response to extracellular matrix stiffness. Mol. Biol. Cell 23, 2583–2592.
Jaffe, A.B., and Hall, A. (2005). Rho GTPases: biochemistry and biology. Annu.
Rev. Cell Dev. Biol. 21, 247–269.
Jilkine, A., Mare´e, A.F., and Edelstein-Keshet, L. (2007). Mathematical model
for spatial segregation of the Rho-family GTPases based on inhibitory cross-
talk. Bull. Math. Biol. 69, 1943–1978.
Kholodenko, B.N. (2006). Cell-signalling dynamics in time and space. Nat. Rev.
Mol. Cell Biol. 7, 165–176.
Krendel, M., Zenke, F.T., and Bokoch, G.M. (2002). Nucleotide exchange fac-
tor GEF-H1 mediates cross-talk betweenmicrotubules and the actin cytoskel-
eton. Nat. Cell Biol. 4, 294–301.
Li, J.J., Bickel, P.J., and Biggin, M.D. (2014). System wide analyses have
underestimated protein abundances and the importance of transcription in
mammals. PeerJ 2, e270.
Machacek, M., Hodgson, L., Welch, C., Elliott, H., Pertz, O., Nalbant, P., Abell,
A., Johnson, G.L., Hahn, K.M., and Danuser, G. (2009). Coordination of Rho
GTPase activities during cell protrusion. Nature 461, 99–103.
Markevich, N.I., Hoek, J.B., and Kholodenko, B.N. (2004). Signaling switches
and bistability arising from multisite phosphorylation in protein kinase cas-
cades. J. Cell Biol. 164, 353–359.
Markevich, N.I., Tsyganov, M.A., Hoek, J.B., and Kholodenko, B.N. (2006).
Long-range signaling by phosphoprotein waves arising from bistability in pro-
tein kinase cascades. Mol. Syst. Biol. 2, 61.
Nguyen, L.K., Degasperi, A., Cotter, P., and Kholodenko, B.N. (2015).
DYVIPAC: an integrated analysis and visualisation framework to probe multi-
dimensional biological networks. Sci. Rep. 5, 12569.
Nikonova, E., Tsyganov, M.A., Kolch, W., Fey, D., and Kholodenko, B.N.
(2013). Control of the G-protein cascade dynamics by GDP dissociation inhib-
itors. Mol. Biosyst. 9, 2454–2462.
Nobes, C.D., and Hall, A. (1995). Rho, rac, and cdc42 GTPases regulate the
assembly of multimolecular focal complexes associated with actin stress
fibers, lamellipodia, and filopodia. Cell 81, 53–62.
Nobes, C.D., and Hall, A. (1999). RhoGTPases control polarity, protrusion, and
adhesion during cell movement. J. Cell Biol. 144, 1235–1244.
Ogasawara, H., and Kawato, M. (2010). The protein kinase Mz network as a
bistable switch to store neuronal memory. BMC Syst. Biol. 4, 181.
Ohta, Y., Hartwig, J.H., and Stossel, T.P. (2006). FilGAP, a Rho- and ROCK-
regulated GAP for Rac binds filamin A to control actin remodelling. Nat. Cell
Biol. 8, 803–814.
Parri, M., and Chiarugi, P. (2010). Rac and Rho GTPases in cancer cell motility
control. Cell Commun. Signal. 8, 23.
Pertz, O. (2010). Spatio-temporal Rho GTPase signaling—where are we now?
J. Cell Sci. 123, 1841–1850.
Pertz, O., Hodgson, L., Klemke, R.L., and Hahn, K.M. (2006). Spatiotemporal
dynamics of RhoA activity in migrating cells. Nature 440, 1069–1072.
Petrie, R.J., Doyle, A.D., and Yamada, K.M. (2009). Random versus direction-
ally persistent cell migration. Nat. Rev. Mol. Cell Biol. 10, 538–549.
Pomerening, J.R., Sontag, E.D., and Ferrell, J.E., Jr. (2003). Building a cell cy-
cle oscillator: hysteresis and bistability in the activation of Cdc2. Nat. Cell Biol.
5, 346–351.
Ridley, A.J., and Hall, A. (1992). The small GTP-binding protein rho regulates
the assembly of focal adhesions and actin stress fibers in response to growth
factors. Cell 70, 389–399.
Ridley, A.J., Paterson, H.F., Johnston, C.L., Diekmann, D., and Hall, A. (1992).
The small GTP-binding protein rac regulates growth factor-induced mem-
brane ruffling. Cell 70, 401–410.
Ridley, A.J., Schwartz, M.A., Burridge, K., Firtel, R.A., Ginsberg, M.H., Borisy,
G., Parsons, J.T., and Horwitz, A.R. (2003). Cell migration: integrating signals
from front to back. Science 302, 1704–1709.48 Cell Systems 2, 38–48, January 27, 2016 ª2016 The AuthorsRiedl, J., Crevenna, A.H., Kessenbrock, K., Yu, J.H., Neukirchen, D., Bista, M.,
Bradke, F., Jenne, D., Holak, T.A., Werb, Z., et al. (2008). Lifeact: a versatile
marker to visualize F-actin. Nat. Methods 5, 605–607.
Saito, K., Ozawa, Y., Hibino, K., and Ohta, Y. (2012). FilGAP, a Rho/Rho-asso-
ciated protein kinase-regulated GTPase-activating protein for Rac, controls
tumor cell migration. Mol. Biol. Cell 23, 4739–4750.
Sanz-Moreno, V., Gadea, G., Ahn, J., Paterson, H., Marra, P., Pinner, S., Sahai,
E., and Marshall, C.J. (2008). Rac activation and inactivation control plasticity
of tumor cell movement. Cell 135, 510–523.
Schwanha¨usser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J.,
Chen, W., and Selbach, M. (2011). Global quantification of mammalian gene
expression control. Nature 473, 337–342.
Semplice, M., Veglio, A., Naldi, G., Serini, G., and Gamba, A. (2012). A bistable
model of cell polarity. PLoS ONE 7, e30977.
Sha, W., Moore, J., Chen, K., Lassaletta, A.D., Yi, C.S., Tyson, J.J., and Sible,
J.C. (2003). Hysteresis drives cell-cycle transitions in Xenopus laevis egg ex-
tracts. Proc. Natl. Acad. Sci. USA 100, 975–980.
Symons, M., and Segall, J.E. (2009). Rac and Rho driving tumor invasion:
who’s at the wheel? Genome Biol. 10, 213.
Takai, Y., Sasaki, T., and Matozaki, T. (2001). Small GTP-binding proteins.
Physiol. Rev. 81, 153–208.
Tsyganov, M.A., Kolch, W., and Kholodenko, B.N. (2012). The topology design
principles that determine the spatiotemporal dynamics of G-protein cascades.
Mol. Biosyst. 8, 730–743.
Tyson, J.J., Chen, K.C., and Novak, B. (2003). Sniffers, buzzers, toggles and
blinkers: dynamics of regulatory and signaling pathways in the cell. Curr.
Opin. Cell Biol. 15, 221–231.
Viaud, J., and Peterson, J.R. (2009). An allosteric kinase inhibitor binds the
p21-activated kinase autoregulatory domain covalently. Mol. Cancer Ther. 8,
2559–2565.
Volinsky, N., Gantman, A., and Yablonski, D. (2006). A Pak- and Pix-dependent
branch of the SDF-1alpha signalling pathway mediates T cell chemotaxis
across restrictive barriers. Biochem. J. 397, 213–222.
von Thun, A., Preisinger, C., Rath, O., Schwarz, J.P., Ward, C., Monsefi, N.,
Rodrı´guez, J., Garcia-Munoz, A., Birtwistle, M., Bienvenut, W., et al. (2013).
Extracellular signal-regulated kinase regulates RhoA activation and tumor
cell plasticity by inhibiting guanine exchange factor H1 activity. Mol. Cell.
Biol. 33, 4526–4537.
Wang, Y., Ku, C.J., Zhang, E.R., Artyukhin, A.B., Weiner, O.D., Wu, L.F., and
Altschuler, S.J. (2013). Identifying network motifs that buffer front-to-back
signaling in polarized neutrophils. Cell Rep. 3, 1607–1616.
Wickham, H. (2009). ggplot2: Elegant Graphics for Data Analysis, Second
Edition (Springer).
Wisniewski, J.R., Zougman, A., Nagaraj, N., and Mann, M. (2009). Universal
sample preparation method for proteome analysis. Nat. Methods 6, 359–362.
Wisniewski, J.R., Hein, M.Y., Cox, J., andMann,M. (2014). A ‘‘proteomic ruler’’
for protein copy number and concentration estimation without spike-in stan-
dards. Mol. Cell. Proteomics 13, 3497–3506.
Wolfram Research (2010). Mathematica Edition, v.8.0 (Wolfram Research).
Xiong, W., and Ferrell, J.E., Jr. (2003). A positive-feedback-based bistable
‘‘memory module’’ that governs a cell fate decision. Nature 426, 460–465.
Zenke, F.T., Krendel, M., DerMardirossian, C., King, C.C., Bohl, B.P., and
Bokoch, G.M. (2004). p21-activated kinase 1 phosphorylates and regulates
14-3-3 binding to GEF-H1, a microtubule-localized Rho exchange factor.
J. Biol. Chem. 279, 18392–18400.
Zhao, Z.S., and Manser, E. (2010). Do PAKs make good drug targets? F1000
Biol. Rep. 2, 70.
Zhao, Z.S., and Manser, E. (2012). PAK family kinases: physiological roles and
regulation. Cell. Logist. 2, 59–68.
